Financial Daily from THE HINDU group of publications
Wednesday, Jul 24, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Mergers & Acquisitions


Ranbaxy arm buys production unit from US company

Our Bureau

NEW DELHI, July 23

IN yet another buy-out, Ranbaxy Laboratories has acquired a liquid manufacturing facility from the New York-based Signature Pharmaceuticals Inc on an asset purchase basis through its wholly-owned subsidiary, Ranbaxy Pharmaceuticals Inc, US.

In an announcement made here today, Ranbaxy said that the fully automated manufacturing and packaging line facility with the latest testing and quality assurance capabilities, would be the first liquid manufacturing unit of the pharma major in the US.

The acquisition would also bring in advanced capabilities for research, development, manufacturing and distribution of controlled substances, the statement said.

This acquisition, Ranbaxy said, would be a strategic fit for its business in the US for the production of certain liquid-based dosage forms that would enable in-house manufacture and strengthen its liquid product pipeline.

It would result in cost savings with respect to products which are currently outsourced and also exhibit validation services for Ranbaxy's products in the US.

The Ranbaxy statement makes no mention of the consideration at which the deal was inked between the two parties.

In September 1995, Ranbaxy acquired Ohm Laboratories which has provided advanced manufacturing capabilities and processes to make `over-the-counter' (OTC) drugs, branded and generic products.

Send this article to Friends by E-Mail

Stories in this Section
Maruti slashes prices of 800 cc models


Tata Engg's Indica to sport a higher price tag `soon'
Honda Motorcycle's Dio set for September debut
Laws complied with on ALBM, says Reliance
Hero Honda to seek shareholders' nod to hike FII limit
Sierra Optima is now arm of US co, changes name
New-look Qualis to hit the road in September
Essar clarifies on RS discussion
Wipro licence for Emuzed
Corporate malfeasance cowers markets
M&M completes Sintered sell-off
Pentamedia to hive off Num TV
ONGC board meet tomorrow to decide on MRPL stake
GAIL board okays 10 pc stake in Haldia Petro
Sun F&C buys out JF Mutuals' two schemes
Ranbaxy arm buys production unit from US company
BIFR seeks Bengal's view on bank guarantee to Jessop
Rain God willing... Madras Fertilizers hopes to make a modest profit
Q1 performance points to recovery
`Post-privatisation, Adilabad spinning mill turns the corner'
I-Sec chief puts in his papers
Adhiraj Sarin to take over as TI's Managing Director


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line